Decreased Gastric Motility [PE] - N0000008640

Pharmacologic Code	N0000008640
Pharmacologic Name	Decreased Gastric Motility
Pharmacologic Uses	GLP-1 receptor agonist
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Decreased Gastric Motility [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-4178	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
	0002-4503	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
	0002-4794	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
	0002-4803	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
	0002-4839	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
	0002-4953	Foundayo	Non-Proprietary Name: Orforglipron	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE